Cargando…
Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study
BACKGROUND: Preliminary evidence suggests that changes in plasma brain-derived neurotrophic factor (BDNF) levels may contribute to the occurrence of chemotherapy-associated cognitive impairment (CACI), and a previous study suggested that carriers of the BDNF Met homozygous genotype are protected fro...
Autores principales: | Ng, Terence, Lee, Ying Yun, Chae, Jung-woo, Yeo, Angie Hui Ling, Shwe, Maung, Gan, Yan Xiang, Ng, Raymond C. H., Chu, Pat Pak Yan, Khor, Chiea Chuen, Ho, Han Kiat, Chan, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735945/ https://www.ncbi.nlm.nih.gov/pubmed/29258453 http://dx.doi.org/10.1186/s12885-017-3861-9 |
Ejemplares similares
-
An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal Study
por: Chan, Alexandre, et al.
Publicado: (2019) -
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer
por: Ng, Terence, et al.
Publicado: (2016) -
Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients
por: Chae, Jung-woo, et al.
Publicado: (2016) -
Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy
por: Tan, Chia Jie, et al.
Publicado: (2018) -
Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore
por: Chan, Alexandre, et al.
Publicado: (2018)